MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition

Gürkan Mollaoglu(Icahn School of Medicine at Mount Sinai), Trudy G. Oliver(Duke University), Kristofer C. Berrett(University of Utah), Paul M. Ballieu(University of Utah), Abbie S. Ireland(Duke University), Christine Heinen(University of Cologne), Annika Marx(University of Cologne), Jane E. Johnson(Southwestern Medical Center), Jessica Kohan(University of Utah), Jason Gertz(University of Utah), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Timothy L. Mosbruger(Johns Hopkins University), Martin L. Sos(German Cancer Research Center), Roman K. Thomas(University of Cologne), Adi F. Gazdar(Weatherford College), Kendall E. Denning(University of Utah), Haixia Cheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Stefanie Böhm(University of Cologne), Robert J. Wechsler‐Reya(Columbia University Irving Medical Center), Martin Peifer(University of Cologne), Milind D. Chalishazar(University of Utah), Johannes Brägelmann(University of Cologne), Julie George(University of Cologne), Anandaroop Mukhopadhyay(University of Utah), Benjamin L. Witt(NorthShore University HealthSystem), Matthew R. Guthrie(University of Utah), Jeffery M. Vahrenkamp(University of Utah), Jun Wang(Wuhan Pulmonary Hospital), İsmail Can(Mayo Clinic in Arizona)
Cancer Cell
January 12, 2017
Cited by 607


Related Papers